Medicine by Prof. Tariq Waseem

27/09/2025

Celebrating World Heart Day 29th September 2025.
Public Awareness Seminar on
"Gender Differences in Cardiovascular Disease Risks and Symptoms."

27/09/2025

Transdermal hormone replacement therapy (HRT) in women with type 2 diabetes (T2D) was associated with a lower risk for ischemic heart disease, whereas oral HRT was linked to increased cardiovascular issues, including a twofold higher risk for pulmonary embolism and a 21% greater risk for ischemic heart disease.

In women with type 2 diabetes, transdermal HRT was associated with reduced ischemic heart disease risk and oral HRT was linked to higher cardiovascular risks, including for pulmonary embolism and ischemic heart disease.

22/09/2025

18/09/2025

Fortnightly Physician Forum Meeting Saleem Memorial Trust Hospital at 2.00 pm on Saturday 20th September 2025.

To join on Zoom click at
https://us06web.zoom.us/j/82270070517?pwd=GPWWifDzaHPvFTrVI3EV8b2cF1d1G1.1
Meeting ID: 822 7007 0517
Passcode: 11223344

16/09/2025

Presented at the EASD Annual Meeting 2025:

In the ATTAIN-1 phase 3 trial, the use of orforglipron, an oral GLP-1 receptor agonist, led to significant mean body-weight reductions in patients with obesity, as compared with placebo. Full trial results:

Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, doubl...

08/09/2025

Baxdrostat: A 'Game Changer' for Hypertension?

A new class of antihypertensive agent that blocks the production of aldosterone — a key hormone believed to drive increased blood pressure — has shown impressive results in one of the first pivotal phase 3 trials in patients with resistant or uncontrolled hypertension.

Use of baxdrostat was associated with a reduction in office-measured systolic blood pressure of around 9 mm Hg at 12 weeks and reductions in 24-hour ambulatory systolic blood pressure of around 15 mm Hg in the BaxHTN trial.

The development of baxdrostat and related drugs is “a triumph of scientific discovery,” following the finding that disturbed aldosterone production to be a key driver of hard-to-control hypertension.

Sources: Medscape/ NEJM/ ESC 2025.

07/09/2025

Join us at Saleem Memorial Trust Hospital Lahore for a comprehensive review on " The Role of Oral Hypoglycemic Agents (OHA) in the Management of Type 2 Diabetes Mellitus." The session will be live on Zoom as well.
Registration is mandatory to earn an e-ceriticate for participation.

To Register click at

https://docs.google.com/forms/d/1fKEQ8vcGfhCWRZ8cz6N_Ay1thLHUCdec9I-D55bu0mk/edit

Zoom Link

https://us06web.zoom.us/j/82319618715?pwd=X9aPIepUeV0sSoiuIbXgaysIFi2LcH.1
Meeting ID: 823 1961 8715
Passcode: 646122

04/09/2025

بلڈ پریشر کا علاج کب اور کیسے؟ناظرین بلڈ پریشر اور آپ کے سلسلہ کی اس نشست میں ہم اس کے علاج میں استعمال ہونے والی دواؤں کے بارے میں کچھ جانیں گے کہ وہ کس طرح...

04/09/2025

Heart Mates, a YouTube and Facebook channel by Prof. Tariq Waseem resumes its series of patient educational videos in FAQ (Frequently Asked Questions) format. Watch this latest video to learn how hypertension, develops, maintained and how antihypertensive are prescribed to treat hypertension as single agent or in combination.
Your feedback will help us to improve the content. Subscribe to this channel, like, and share to spread the message. Also suggest further topics, diseases and medications for our coming videos.

بلڈ پریشر کا علاج کب اور کیسے؟ناظرین بلڈ پریشر اور آپ کے سلسلہ کی اس نشست میں ہم اس کے علاج میں استعمال ہونے والی دواؤں کے بارے میں کچھ جانیں گے کہ وہ کس طرح...

30/08/2025

Today's Case at Physician Forum meeting:

A 55-year-old lady who is known Diabetic and hypertensive and also has a biopsy proven CA right breast for 1 year(No treatment done except desi totkas). She presented with a one month H/O febrile illness treated as Enteric (Meropenam +Oxidil)
Left hemiparesis was noted in ER. Lab data showed. Normocytic normochromic anaemia, thrombocytopenia, Shistocytes on smear, INR 1.6, Bilirubin 1.5, Normal Transaminases, raised LDH. RFTs were normal. CT and MRI suggested multiple lacunar infarcts. Echocardiography and Doppler were normal. CXR showed right pleural effusion, which was transudative on analysis.

A provisional diagnosis of TTP/ DIC secondary to CA was made as there was quite a bit of overlap for these two conditions.

The oncologist was consulted, and the biopsy performed again. HER negative CA confirmed.

Her fever didn't respond to treatment.
Terminally, she developed ARDS and family signed for DNR and DNV status.
Plasmapharesis was refused by family.

Comments and suggestions are welcome.

29/08/2025

Fortnightly Physician forum meeting at Saleem Memorial Hospital is rescheduled on every 1st and 3rd Saturday of the month at 2.00 pm
Every one is welcome to join either in person or on Zoom.

Click here to join
https://us06web.zoom.us/j/9023051234?pwd=IzntB8Ga23QUeHutw0JpnjhyW1uw48.1&omn=84750691801

Meeting ID: 902 305 1234
Passcode: 902 305 1234